Lantheus Holdings, Inc. Cash and Cash Equivalents
Lantheus Holdings, Inc. (LNTH) had Cash and Cash Equivalents of $593.30 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $593.30M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $498.58M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $359.12M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $382.01M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $593.30M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $498.58M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $359.12M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $382.01M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $695.57M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $938.53M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $912.81M 10-K · filed 2026-02-26 |
| 2024-09-30 | $866.39M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $757.02M 10-Q · filed 2025-08-06 |
| 2024-03-31 | $718.28M 10-Q · filed 2025-05-07 |
| 2023-12-31 | $713.66M 10-K · filed 2026-02-26 |
| 2023-09-30 | $614.13M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $414.08M 10-Q · filed 2024-07-31 |
| 2023-03-31 | $470.86M 10-Q · filed 2024-05-02 |
| 2022-12-31 | $415.65M 10-K · filed 2025-02-26 |
| 2022-09-30 | $257.26M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $171.43M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $105.36M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $98.51M 10-K · filed 2024-02-22 |
| 2021-09-30 | $91.47M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $91.50M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $68.86M 10-Q · filed 2022-04-29 |
| 2020-12-31 | $79.61M 10-K · filed 2023-02-23 |
| 2020-09-30 | $87.99M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $90.31M 10-Q · filed 2021-07-28 |
| 2020-03-31 | $95.71M 10-Q · filed 2021-05-04 |
| 2019-12-31 | $92.92M 10-K · filed 2022-02-24 |
| 2019-09-30 | $78.06M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $56.88M 10-Q · filed 2020-07-31 |
| 2019-03-31 | $112.06M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $113.40M 10-K · filed 2021-02-25 |
| 2018-09-30 | $104.58M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $86.46M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $73.74M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $76.29M 10-K · filed 2019-02-20 |
| 2017-09-30 | $68.08M 10-Q · filed 2018-10-30 |
| 2017-06-30 | $57.15M 10-Q · filed 2018-08-01 |
| 2017-03-31 | $40.88M 10-Q · filed 2018-05-02 |
| 2016-12-31 | $51.18M 10-K · filed 2019-02-20 |
| 2016-09-30 | $53.20M 10-Q · filed 2017-11-02 |
| 2016-06-30 | $54.85M 10-Q · filed 2017-08-01 |
| 2016-03-31 | $38.88M 10-Q · filed 2017-05-02 |
| 2015-12-31 | $28.60M 10-K · filed 2019-02-20 |
| 2015-09-30 | $21.92M 10-Q · filed 2016-11-01 |
| 2015-06-30 | $22.20M 10-Q · filed 2016-08-04 |
| 2015-03-31 | $30.74M 10-Q · filed 2016-05-03 |
| 2014-12-31 | $19.74M 10-K · filed 2018-02-26 |
| 2014-09-30 | $27.13M 10-Q · filed 2015-11-04 |
| 2014-06-30 | $16.02M 10-Q · filed 2015-08-05 |
| 2013-12-31 | $18.58M 10-K · filed 2017-02-23 |
| 2012-12-31 | $33.32M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |